Which medication is a cornerstone in treating myxedema coma?

Which medication is a cornerstone in treating myxedema coma?

• A. Levothyroxine PO
• B. IV levothyroxine
• C. Methimazole
• D. Hydrocortisone only

Answer: (B)

In myxedema coma, the priority is rapid, reliable thyroid hormone replacement because the patient is critically hypothyroid and may not tolerate or absorb oral meds. Intravenous levothyroxine provides predictable bioavailability and acts quickly, which is essential in this emergency setting. Oral levothyroxine is unreliable when a patient is comatose or has ileus or poor GI absorption, so it’s not the best choice here. Dosing often starts with a IV loading amount around 200–400 mcg, followed by about 1.6 mcg/kg/day IV, with adjustments based on clinical response and labs. Some protocols also consider adding IV liothyronine (T3) for faster effect, but the foundation remains IV levothyroxine. Hydrocortisone is given empirically if adrenal insufficiency cannot be ruled out, but it is not a standalone treatment and does not replace thyroid hormone. Methimazole would address hyperthyroidism, not hypothyroidism, so it’s not appropriate in this context.

In myxedema coma, the priority is rapid, reliable thyroid hormone replacement because the patient is critically hypothyroid and may not tolerate or absorb oral meds. Intravenous levothyroxine provides predictable bioavailability and acts quickly, which is essential in this emergency setting. Oral levothyroxine is unreliable when a patient is comatose or has ileus or poor GI absorption, so it’s not the best choice here. Dosing often starts with a IV loading amount around 200–400 mcg, followed by about 1.6 mcg/kg/day IV, with adjustments based on clinical response and labs. Some protocols also consider adding IV liothyronine (T3) for faster effect, but the foundation remains IV levothyroxine. Hydrocortisone is given empirically if adrenal insufficiency cannot be ruled out, but it is not a standalone treatment and does not replace thyroid hormone. Methimazole would address hyperthyroidism, not hypothyroidism, so it’s not appropriate in this context.